Docket Management
Docket: 00N-1256 - Over-the-Counter Products
Comment Number: EC -71

Accepted - Volume 6

Comment Record
Commentor Ms. Elizabeth Hermann Date/Time 2000-06-29 01:59:31
Organization Ms. Elizabeth Hermann
Category Individual

Comments for FDA General
Questions
1. General Comments Changing medications needed for chronic disease from prescription to non-prescription will enable insurance companies to decline payment. So which money talks loudest to the F.D.A. -- that of the drug companies, or that of the managed care insurance companies? America's aging population needs heart medicine, asthma medicine, etc. in order to live just as much as they need food and water. Whether the medicine costs $17 non-prescription or $77 prescription is not the point; insurance reimbursement is the point.




EC -71